NEK2
Basic information
Region (hg38): 1:211658657-211675630
Links
Phenotypes
GenCC
Source:
- retinitis pigmentosa 67 (Limited), mode of inheritance: AR
- retinitis pigmentosa (Supportive), mode of inheritance: AD
- retinitis pigmentosa 67 (Limited), mode of inheritance: AR
- retinitis pigmentosa 67 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Retinitis pigmentosa 67 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 24043777 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NEK2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 44 | 52 | ||||
missense | 120 | 127 | ||||
nonsense | 11 | 11 | ||||
start loss | 0 | |||||
frameshift | 8 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 5 | 5 | 10 | |||
non coding | 14 | 19 | ||||
Total | 0 | 5 | 144 | 62 | 11 |
Variants in NEK2
This is a list of pathogenic ClinVar variants found in the NEK2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-211663432-C-T | Uncertain significance (Mar 09, 2022) | |||
1-211663444-C-G | not specified | Uncertain significance (May 26, 2024) | ||
1-211663446-G-T | Uncertain significance (Aug 21, 2022) | |||
1-211663447-T-C | not specified • Retinal dystrophy | Benign (Jan 31, 2024) | ||
1-211663449-T-C | Uncertain significance (Aug 31, 2022) | |||
1-211663457-A-G | Uncertain significance (Aug 24, 2022) | |||
1-211663459-T-C | Likely benign (Jul 12, 2023) | |||
1-211663464-A-C | Uncertain significance (Feb 28, 2023) | |||
1-211663464-A-G | Uncertain significance (Sep 27, 2022) | |||
1-211663488-C-T | Uncertain significance (Oct 05, 2022) | |||
1-211663488-C-CTTGA | Uncertain significance (Nov 29, 2021) | |||
1-211663491-G-A | Uncertain significance (Mar 21, 2021) | |||
1-211663493-GC-G | Retinal dystrophy | Likely pathogenic (Oct 01, 2023) | ||
1-211663494-C-G | not specified | Uncertain significance (Nov 18, 2022) | ||
1-211663496-C-T | Uncertain significance (Oct 24, 2022) | |||
1-211663497-G-A | Uncertain significance (Dec 18, 2023) | |||
1-211663507-A-G | NEK2-related disorder | Benign (Nov 13, 2023) | ||
1-211663510-G-A | Likely benign (Dec 05, 2022) | |||
1-211663537-C-T | Likely benign (Oct 29, 2022) | |||
1-211663538-T-C | Uncertain significance (Jun 17, 2023) | |||
1-211663541-G-T | Uncertain significance (Aug 23, 2022) | |||
1-211663550-G-A | Uncertain significance (Aug 30, 2023) | |||
1-211663564-A-C | Likely benign (Oct 28, 2022) | |||
1-211663565-G-C | Uncertain significance (Mar 08, 2023) | |||
1-211663580-A-G | Uncertain significance (Aug 28, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NEK2 | protein_coding | protein_coding | ENST00000366999 | 8 | 12847 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000115 | 0.988 | 125653 | 0 | 95 | 125748 | 0.000378 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.30 | 188 | 245 | 0.767 | 0.0000135 | 2904 |
Missense in Polyphen | 55 | 83.402 | 0.65946 | 910 | ||
Synonymous | 0.206 | 87 | 89.5 | 0.972 | 0.00000463 | 839 |
Loss of Function | 2.28 | 14 | 26.8 | 0.523 | 0.00000188 | 286 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00101 | 0.000979 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000584 | 0.000545 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000261 | 0.000261 |
Other | 0.000340 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Protein kinase which is involved in the control of centrosome separation and bipolar spindle formation in mitotic cells and chromatin condensation in meiotic cells. Regulates centrosome separation (essential for the formation of bipolar spindles and high-fidelity chromosome separation) by phosphorylating centrosomal proteins such as CROCC, CEP250 and NINL, resulting in their displacement from the centrosomes. Regulates kinetochore microtubule attachment stability in mitosis via phosphorylation of NDC80. Involved in regulation of mitotic checkpoint protein complex via phosphorylation of CDC20 and MAD2L1. Plays an active role in chromatin condensation during the first meiotic division through phosphorylation of HMGA2. Phosphorylates: PPP1CC; SGO1; NECAB3 and NPM1. Essential for localization of MAD2L1 to kinetochore and MAPK1 and NPM1 to the centrosome. Phosphorylates CEP68 and CNTLN directly or indirectly (PubMed:24554434). NEK2-mediated phosphorylation of CEP68 promotes CEP68 dissociation from the centrosome and its degradation at the onset of mitosis (PubMed:25704143). Involved in the regulation of centrosome disjunction (PubMed:26220856). {ECO:0000269|PubMed:11742531, ECO:0000269|PubMed:12857871, ECO:0000269|PubMed:14978040, ECO:0000269|PubMed:15358203, ECO:0000269|PubMed:15388344, ECO:0000269|PubMed:17283141, ECO:0000269|PubMed:17621308, ECO:0000269|PubMed:17626005, ECO:0000269|PubMed:18086858, ECO:0000269|PubMed:18297113, ECO:0000269|PubMed:20034488, ECO:0000269|PubMed:21076410, ECO:0000269|PubMed:24554434, ECO:0000269|PubMed:25704143, ECO:0000269|PubMed:26220856}.; FUNCTION: Isoform 2: Not present in the nucleolus and, in contrast to isoform 1, does not phosphorylate and activate NEK11 in G1/S- arrested cells. {ECO:0000269|PubMed:15161910}.;
- Disease
- DISEASE: Retinitis pigmentosa 67 (RP67) [MIM:615565]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:24043777}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Regulation of PLK1 Activity at G2/M Transition;Recruitment of mitotic centrosome proteins and complexes;Loss of Nlp from mitotic centrosomes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;AURKA Activation by TPX2;G2/M Transition;Mitotic G2-G2/M phases;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;M Phase;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC/C-mediated degradation of cell cycle proteins;Regulation of mitotic cell cycle;Cell Cycle;Cell Cycle, Mitotic;Anchoring of the basal body to the plasma membrane;FOXM1 transcription factor network;Cilium Assembly;Organelle biogenesis and maintenance
(Consensus)
Recessive Scores
- pRec
- 0.205
Intolerance Scores
- loftool
- 0.604
- rvis_EVS
- -0.31
- rvis_percentile_EVS
- 31.93
Haploinsufficiency Scores
- pHI
- 0.852
- hipred
- Y
- hipred_score
- 0.715
- ghis
- 0.661
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.995
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nek2
- Phenotype
Zebrafish Information Network
- Gene name
- nek2
- Affected structure
- retinal rod cell
- Phenotype tag
- abnormal
- Phenotype quality
- malformed
Gene ontology
- Biological process
- mitotic sister chromatid segregation;G2/M transition of mitotic cell cycle;mitotic cell cycle;blastocyst development;protein phosphorylation;chromosome segregation;regulation of mitotic nuclear division;regulation of G2/M transition of mitotic cell cycle;positive regulation of telomere maintenance via telomerase;negative regulation of DNA binding;regulation of mitotic centrosome separation;protein autophosphorylation;spindle assembly;centrosome separation;cell division;meiotic cell cycle;positive regulation of telomerase activity;regulation of attachment of spindle microtubules to kinetochore;mitotic spindle assembly;ciliary basal body-plasma membrane docking;negative regulation of centriole-centriole cohesion;positive regulation of telomere capping
- Cellular component
- kinetochore;condensed chromosome kinetochore;condensed nuclear chromosome;spindle pole;nucleus;nucleoplasm;nucleolus;centrosome;cytosol;microtubule;midbody;protein-containing complex
- Molecular function
- protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;protein phosphatase binding;metal ion binding